These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 28039278

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition by Avibactam and Clavulanate of the β-Lactamases KPC-2 and CTX-M-15 Harboring the Substitution N132G in the Conserved SDN Motif.
    Ourghanlian C, Soroka D, Arthur M.
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069651
    [Abstract] [Full Text] [Related]

  • 3. Hydrolysis of clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical SDN motif.
    Soroka D, Li de la Sierra-Gallay I, Dubée V, Triboulet S, van Tilbeurgh H, Compain F, Ballell L, Barros D, Mainardi JL, Hugonnet JE, Arthur M.
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5714-20. PubMed ID: 26149997
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of β-lactamase inhibition on the activity of ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus.
    Dubée V, Soroka D, Cortes M, Lefebvre AL, Gutmann L, Hugonnet JE, Arthur M, Mainardi JL.
    Antimicrob Agents Chemother; 2015 May; 59(5):2938-41. PubMed ID: 25733512
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.
    Winkler ML, Papp-Wallace KM, Bonomo RA.
    J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381
    [Abstract] [Full Text] [Related]

  • 9. Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations.
    Kurz SG, Wolff KA, Hazra S, Bethel CR, Hujer AM, Smith KM, Xu Y, Tremblay LW, Blanchard JS, Nguyen L, Bonomo RA.
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6085-96. PubMed ID: 24060876
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis of Avibactam Derivatives and Activity on β-Lactamases and Peptidoglycan Biosynthesis Enzymes of Mycobacteria.
    Edoo Z, Iannazzo L, Compain F, Li de la Sierra Gallay I, van Tilbeurgh H, Fonvielle M, Bouchet F, Le Run E, Mainardi JL, Arthur M, Ethève-Quelquejeu M, Hugonnet JE.
    Chemistry; 2018 Jun 07; 24(32):8081-8086. PubMed ID: 29601108
    [Abstract] [Full Text] [Related]

  • 12. Structural and sequence analysis of class A β-lactamases with respect to avibactam inhibition: impact of Ω-loop variations.
    Lahiri SD, Bradford PA, Nichols WW, Alm RA.
    J Antimicrob Chemother; 2016 Oct 07; 71(10):2848-55. PubMed ID: 27402011
    [Abstract] [Full Text] [Related]

  • 13. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.
    Papp-Wallace KM, Winkler ML, Taracila MA, Bonomo RA.
    Antimicrob Agents Chemother; 2015 Jul 07; 59(7):3710-7. PubMed ID: 25666153
    [Abstract] [Full Text] [Related]

  • 14. Avibactam and inhibitor-resistant SHV β-lactamases.
    Winkler ML, Papp-Wallace KM, Taracila MA, Bonomo RA.
    Antimicrob Agents Chemother; 2015 Jul 07; 59(7):3700-9. PubMed ID: 25691639
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Structure of the covalent adduct formed between Mycobacterium tuberculosis beta-lactamase and clavulanate.
    Tremblay LW, Hugonnet JE, Blanchard JS.
    Biochemistry; 2008 May 13; 47(19):5312-6. PubMed ID: 18422342
    [Abstract] [Full Text] [Related]

  • 17. Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of Mycobacterium tuberculosis.
    Nantongo M, Nguyen DC, Bethel CR, Taracila MA, Li Q, Dousa KM, Shin E, Kurz SG, Nguyen L, Kreiswirth BN, Boom WH, Plummer MS, Bonomo RA.
    ACS Infect Dis; 2024 May 10; 10(5):1767-1779. PubMed ID: 38619138
    [Abstract] [Full Text] [Related]

  • 18. Structural Insights into the Inhibition of the Extended-Spectrum β-Lactamase PER-2 by Avibactam.
    Ruggiero M, Papp-Wallace KM, Brunetti F, Barnes MD, Bonomo RA, Gutkind G, Klinke S, Power P.
    Antimicrob Agents Chemother; 2019 Sep 10; 63(9):. PubMed ID: 31235626
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.